home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

dPCR, qPCR and RT-qPCR: Advantages and Challenges in Pre-clinical and Clinical Development

  August 28, 2023  
Xtalks, online
2023 -10-13

Regulated digital polymerase chain reaction (dPCR), quantitative polymerase chain reaction (qPCR) and reverse transcriptase quantitative polymerase chain reaction (qRT-PCR) are extensively utilized to support biodistribution, vector shedding, gene expression, chimeric antigen receptor (CAR) T cell therapy and oncolytic viral bioanalytical studies.
In this presentation, the featured speakers will review the advantages and disadvantages of dPCR, qPCR and qRT-PCR as it relates to vaccine and biotherapeutic research. They will also discuss the current method development and method validation best practices, context of use and level of regulatory compliance required to support bioanalysis in pre-clinical and clinical settings.
Join this informative webinar to gain insights into the best use of PCR methods in vaccine and biotherapeutic research in pre-clinical and clinical development.
Organized by: Xtalks
Invited Speakers: Manisha R. Diaz, PhD, Associate Director of Research and Development, Eurofins Viracor BioPharma Services Deepak Tomar, PhD, Senior Scientific Lab Lead, Eurofins Bioanalytical Services Erik Jerks, PhD, Director of Bioanalytical Services, Eurofins Bioanalytical Services
Deadline for Abstracts: 2023 -10-13
Registration: Free registration
E-mail: ajuurinen@xtalks.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.